Willis-Knighton Health System is expanding its clinical trials of monoclonal antibodies for outpatient treatment of people infected with COVID-19. Willis-Knighton ...
PLEASE LOG IN FOR PREMIUM CONTENT. Our website requires visitors to log in to view the best local news. Not yet a subscriber? Subscribe today!